In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

The Drugs Technical Advisory Board (DTAB) has opined that manufacturers of ranitidine - a drug used to treat indigestion, heartburn and acid reflux - should monitor the N-nitrosodimethylamine (NDMA) ...

Zantac (ranitidine) litigation settlements | Regulatory NewsThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority ...

Ranitidine was one of the most common medications used to treat gastroesophageal reflux disease and peptic ulcer disease for several decades until the FDA found N-nitrosodimethylamine (NDMA) in ...

There is no link between the use of ranitidine, applied for treating and preventing gastric ulcers, and cancer, according to a recent study. Conducted in South Korea, the study, published in the ...

Experts at the US Federal Court state that links between the Ranitidine and cancer (which include lung, liver, and kidney cancer) are illegitimate.

The same day that Valisure announced a “Citizen Petition” with the FDA urging a recall of ranitidine, numerous lawsuits were filed against drug manufacturers.